The latest news, developments and research findings from all fields of science including biology, chemistry, physics, psychology, sociology and space, including news on the latest policies regulating this sector.
Scientists at the Japan Advanced Institute of Science and Technology are trying to use neuroscience to create emotionally intelligent robots - which process more than logical instructions.
The star, AG Carinae, is fighting with gravity and radiation on the edge of death - Hubble also captures the five light-years wide nebula that comes with it.
India broke records on Thursday (23 April) as more than 310,000 new COVID cases were documented in one day - is the Indian 'double mutation', B1617, as infectious as the UK mutation?
Researchers believe that they have found a PTSD marker in the brain region associated with emotional regulation - with the marker being strongest in people with "impaired executive dysfunction".
The mysterious fast radio bursts (FRBs) in space now include lower frequency radio waves than scientists have ever detected - complicating their attempt to find the source.
Yesterday (19 April), the Ingenuity drone on Mars became the first in history to make a controlled flight on another planet - climbing to a height of 10 feet and then touching back down on the red surface.
Pfizer CEO Albert Bourla suggested that fully vaccinated people would need their third vaccine dose, maybe 12 months after they got their second - the EU is currently in talks to secure a further 1.8 billion doses.
Dean Billington, Chief Operating Officer at Brains Bioceutical, discusses the pivotal role of the life science sector in spearheading the post-Covid economic recovery and why driving forward R&D and innovation should be the nation’s top priority.
An international study examined hospitalised COVID patients across 11 countries - finding that obese patients are 73% more likely to need invasive respiratory support.
Uninfected people lived with one infected individual as part of the study - the COVID antibody drug gave them 72% protection against catching the virus themselves.
Here, we learn how world leading supplier Bioquell devised a PRP for a Biopharmaceutical Production Facility ensuring high-level bio-decontamination in the event of contamination.
